Trends in Malaria Morbidity in M'lomp, Senegal
Author Information
Author(s): Sophie Sarrassat, Paul Senghor, Jean Yves Le Hesran
Primary Institution: Unité de Recherche, Santé de la mère et de l'enfant en milieu tropical, IRD, Université Pairs Descartes, Paris, France
Hypothesis
What is the impact of artesunate plus amodiaquine combination therapy on malaria morbidity in M'lomp village?
Conclusion
The introduction of artesunate plus amodiaquine did not significantly reduce malaria morbidity in M'lomp, and other factors like rainfall may have influenced the results.
Supporting Evidence
- The total number of fevers treated with antimalarials decreased from 2824 in 1998 to 945 in 2002.
- The percentage of uncomplicated malaria cases treated with ACT increased from 18.9% in 2000 to 64.0% in 2002.
- The incidence rate of uncomplicated malaria fell from 46.1% in 2001 to 37.5% in 2002.
Takeaway
This study looked at how a new malaria treatment affected sick people in a village. Even though fewer people got sick, it wasn't clear if the new medicine was the reason.
Methodology
Data on fevers and malaria cases were collected from health records at the dispensary from 1998 to 2002, and statistical tests were used to analyze the data.
Potential Biases
Potential bias due to reliance on health records and the context of ACT administration.
Limitations
The study could not establish a clear impact of ACT due to low coverage and other confounding factors like rainfall.
Participant Demographics
The study involved inhabitants of M'lomp village, with a population of about 8,000 in 2000.
Statistical Information
P-Value
p<0.0001
Confidence Interval
[0.44–0.69]
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website